Evidence map›Paper›PMID 22844257›Full record

ArticlePLoS genetics2012

F-box protein specificity for g1 cyclins is dictated by subcellular localization.

Benjamin D Landry, John P Doyle, David P Toczyski, Jennifer A Benanti

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Induced proximity-based therapeutic modalities.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mad3 modulates the GScience advances · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Benjamin D LandryProgram in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA, USA.
John P Doyle
David P Toczyski
Jennifer A Benanti
University of California, San Francisco · USUniversity of Massachusetts Chan Medical School · US

Funding

Structure and function of the APCR01GM070539 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TOCZYSKI, DAVID PAUL · 2004 to 2015
$3.9M
Regulation of Cellular Growth and Division by Ubiquitin-Mediated ProteolysisR00GM085013 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BENANTI, JENNIFER A · 2010 to 2012
$742k
NIGMS NIH HHS R00 GM085013NIGMS NIH HHS R00GM085013NIGMS NIH HHS R01 GM070539NIGMS NIH HHS R01GM070539
6 · The paper itself

Abstract

Levels of G1 cyclins fluctuate in response to environmental cues and couple mitotic signaling to cell cycle entry. The G1 cyclin Cln3 is a key regulator of cell size and cell cycle entry in budding yeast. Cln3 degradation is essential for proper cell cycle control; however, the mechanisms that control Cln3 degradation are largely unknown. Here we show that two SCF ubiquitin ligases, SCF(Cdc4) and SCF(Grr1), redundantly target Cln3 for degradation. While the F-box proteins (FBPs) Cdc4 and Grr1 were previously thought to target non-overlapping sets of substrates, we find that Cdc4 and Grr1 each bind to all 3 G1 cyclins in cell extracts, yet only Cln3 is redundantly targeted in vivo, due in part to its nuclear localization. The related cyclin Cln2 is cytoplasmic and exclusively targeted by Grr1. However, Cdc4 can interact with Cdk-phosphorylated Cln2 and target it for degradation when cytoplasmic Cdc4 localization is forced in vivo. These findings suggest that Cdc4 and Grr1 may share additional redundant targets and, consistent with this possibility, grr1Δ cdc4-1 cells demonstrate a CLN3-independent synergistic growth defect. Our findings demonstrate that structurally distinct FBPs are capable of interacting with some of the same substrates; however, in vivo specificity is achieved in part by subcellular localization. Additionally, the FBPs Cdc4 and Grr1 are partially redundant for proliferation and viability, likely sharing additional redundant substrates whose degradation is important for cell cycle progression.

Indexed as

Cell Cycle ProteinsCyclinsF-Box ProteinsSaccharomyces cerevisiae ProteinsUbiquitin-Protein LigasesCell Cycle CheckpointsCell DivisionGene Expression Regulation, FungalMutationPhosphorylationProtein BindingProteolysisSaccharomyces cerevisiaeSignal TransductionSKP Cullin F-Box Protein LigasesSubstrate SpecificityCDC4 protein, S cerevisiaeCell Cycle ProteinsCLN2 protein, S cerevisiaeCLN3 protein, S cerevisiaeCyclinsF-Box ProteinsGRR1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSKP Cullin F-Box Protein LigasesUbiquitin-Protein Ligases

Identifiers

PMID22844257
PMCPMC3405998
OpenAlexW2156089739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.